Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
Operating Expenses | 41,640 | 32,289 | 33,004 | 26,341 | 25,301 |
Operating Income | -41,640 | -32,289 | -33,004 | -26,341 | -25,301 |
Other Income | 530 | 497 | 507 | 471 | 225 |
Pre-tax Income | -41,110 | -31,792 | -32,497 | -25,870 | -25,076 |
Net Income Continuous | -41,166 | -31,792 | -32,497 | -25,870 | -25,076 |
Net Income | $-41,166 | $-31,792 | $-32,497 | $-25,870 | $-25,076 |
EPS Basic Total Ops | -0.81 | -0.63 | -0.65 | -0.52 | -0.56 |
EPS Basic Continuous Ops | -0.81 | -0.63 | -0.65 | -0.52 | -0.56 |
EPS Diluted Total Ops | -0.81 | -0.63 | -0.65 | -0.52 | -0.56 |
EPS Diluted Continuous Ops | -0.81 | -0.63 | -0.65 | -0.52 | -0.56 |
EBITDA(a) | $-41,343 | $-31,896 | $-32,601 | $-25,957 | $-24,989 |